Jefferies Financial Group Inc.

Position in CRL — Charles River Laboratories International, Inc.

CIK 96223 NEW YORK, NY

Position in CRL

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$4,143,453

+$3,361,153 QoQ

Shares Held

18,270

+265.4% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#143

of 564 holders

Holding Since

Sep 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Jefferies Financial Group Inc. holds $239,574,818 across 21 Diagnostics & Research names. CRL ranks #8 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	193,340	$96,932,942
2	GRAL	GRAIL, Inc.	724,000	$49,427,480
3	QGEN	Qiagen N.V.	618,798	$24,195,001
4	IQV	Iqvia Holdings Inc.	84,902	$16,404,764
5	CSTL	Castle Biosciences Inc	647,391	$15,440,275
6	A	Agilent Technologies, Inc.	63,180	$8,392,199
7	GH	Guardant Health, Inc.	35,629	$5,345,418
8	CRL	Charles River Laboratories International, Inc. This page	18,270	$4,143,453

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,143,453	18,270	+265.4%	Shares	Defined	2026-08-17
2025-09-30	$782,300	5,000	-43.6%	Shares	Defined	2025-11-13
2025-06-30	$1,346,148	8,872	-34.8%	Shares	Defined	2025-08-12
2025-03-31	$2,049,179	13,614	-23.5%	Shares	Defined	2025-05-08
2024-12-31	$3,286,249	17,802	+226.7%	Shares	Defined	2025-02-27
2024-09-30	$1,073,289	5,449	-37.5%	Shares	Defined	2024-11-14
2024-03-31	$2,362,684	8,720	+627.3%	Shares	Defined	2024-05-13
2023-09-30	$234,980	1,199	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.